Mouse LYVE1 Peptide (DAG-P1772) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use

Mouse LYVE1 peptide (DAG-P1772) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes. Specificity Mainly expressed in endothelial cells lining lymphatic vessels. Nature Synthetic Expression System N/A Conjugate Unconjugated Sequence Similarities Contains 1 Link domain. Cellular Localization Membrane. Localized to the plasma membrane and in vesicles near extranuclear membranes which may represent trans-Golgi network (TGN) and endosomes/prelysosomeal compartments. Undergoes ligand-dependent internalization and recycling at the cell surface. Procedure None Format Liquid Preservative None Storage Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. Information available upon request. ANTIGEN GENE INFORMATION Gene Name Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 [ Mus musculus (house mouse) ] Official Symbol LYVE1 Synonyms LYVE1; lymphatic vessel endothelial hyaluronan receptor 1; Xlkd1; Lyve-1; Crsbp-1; 1200012G08Rik; lymphatic vessel endothelial hyaluronic acid receptor 1; extra cellular link 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved domain-containing 1; lymphatic vessel endothelial HA recptor-1; lymphatic vessel endothelial HA receptor-1; extracellular link domain-containing protein 1; cell surface retention sequence binding protein-1; cell surface retention sequence-binding protein 1; Entrez Gene ID 114332 mRNA Refseq NM_053247.4 Protein Refseq NP_444477.2 UniProt ID Q8BHC0 Chromosome Location 7; 7 F2 Pathway Disease, organism-specific biosystem; Glycosaminoglycan metabolism, organism-specific biosystem; Hyaluronan metabolism, organism-specific biosystem; Hyaluronan uptake and degradation, organism-specific biosystem; MPS I - Hurler syndrome, organism-specific biosystem; MPS II - Hunter syndrome, organism-specific biosystem; MPS IIIA - Sanfilippo syndrome A, organism-specific biosystem; MPS IIIB - Sanfilippo syndrome B, organism-specific biosystem; MPS IIIC - Sanfilippo syndrome C, organism-specific Function hyaluronic acid binding; transmembrane signaling receptor activity; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 2 © Creative Diagnostics All Rights Reserved.

Copy Link

Recommended publications

Mouse Lyve1 Knockout Project (CRISPR/Cas9)
https://www.alphaknockout.com Mouse Lyve1 Knockout Project (CRISPR/Cas9) Objective: To create a Lyve1 knockout Mouse model (C57BL/6N) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Lyve1 gene (NCBI Reference Sequence: NM_053247 ; Ensembl: ENSMUSG00000030787 ) is located on Mouse chromosome 7. 6 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 6 (Transcript: ENSMUST00000033050). Exon 2~5 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for one allele display enlarged lymphatic vessels and increased interstitial-lymphatic flow. However, mice homozygous for a second allele do not display any abnormalities in the lymphatic system. Exon 2 starts from about 9.01% of the coding region. Exon 2~5 covers 71.8% of the coding region. The size of effective KO region: ~6930 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 Legends Exon of mouse Lyve1 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis.
[Show full text]
Quantitative Lymphatic Vessel Trait Analysis Suggests Vcam1 As Candidate Modifier Gene of Inflammatory Bowel Disease
Genes and Immunity (2010) 11, 219–231 & 2010 Macmillan Publishers Limited All rights reserved 1466-4879/10 $32.00 www.nature.com/gene ORIGINAL ARTICLE Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease G Jurisic1, JP Sundberg2, A Bleich3, EH Leiter2, KW Broman4, G Buechler3, L Alley2, D Vestweber5 and M Detmar1 1Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland; 2The Jackson Laboratory, Bar Harbor, ME, USA; 3Institute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany; 4Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA and 5Max Planck Institute of Molecular Biomedicine, Mu¨nster, Germany Inflammatory bowel disease (IBD) is a chronic debilitating disease resulting from a complex interaction of multiple genetic factors with the environment. To identify modifier genes of IBD, we used an F2 intercross of IBD-resistant C57BL/6J-Il10À/À mice and IBD-susceptible C3H/HeJBir-Il10À/À (C3Bir-Il10À/À) mice. We found a prominent involvement of lymphatic vessels in IBD and applied a scoring system to quantify lymphatic vascular changes. Quantitative trait locus (QTL) analyses revealed a large-effect QTL on chromosome 3, mapping to an interval of 43.6 Mbp. This candidate interval was narrowed by fine mapping to 22 Mbp, and candidate genes were analyzed by a systems genetics approach that included quantitative gene expression profiling, search for functional polymorphisms, and haplotype block analysis. We identified vascular adhesion molecule 1 (Vcam1) as a candidate modifier gene in the interleukin 10-deficient mouse model of IBD.
[Show full text]
Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulﬁllment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacriﬁces. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
[Show full text]
Universidad Autónoma De Madrid
Universidad Autónoma de Madrid Departamento de Bioquímica Identification of the substrates of the protease MT1-MMP in TNFα- stimulated endothelial cells by quantitative proteomics. Analysis of their potential use as biomarkers in inflammatory bowel disease. Agnieszka A. Koziol Tesis doctoral Madrid, 2013 2 Departamento de Bioquímica Facultad de Medicina Universidad Autónoma de Madrid Identification of the substrates of the protease MT1-MMP in TNFα- stimulated endothelial cells by quantitative proteomics. Analysis of their potential use as biomarkers in inflammatory bowel disease. Memoria presentada por Agnieszka A. Koziol licenciada en Ciencias Biológicas para optar al grado de Doctor. Directora: Dra Alicia García Arroyo Centro Nacional de Investigaciones Cardiovasculares (CNIC) Madrid, 2013 3 4 ACKNOWLEDGEMENTS - ACKNOWLEDGEMENTS - First and foremost I would like to express my sincere gratitude to my supervisor Dr. Alicia García Arroyo for giving me the great opportunity to study under her direction. Her encouragement, guidance and support from the beginning to the end, enabled me to develop and understand the subject. Her feedback to this manuscript, critical reading and corrections was inappreciable to finish this dissertation. Next, I would like to express my gratitude to those who helped me substantially along the way. To all members of MMPs’ lab, for their interest in the project, teaching me during al these years and valuable contribution at the seminary discussion. Without your help it would have not been possible to do some of those experiments. Thank you all for creating a nice atmosphere at work and for being so good friends in private. I would like to also thank all of the collaborators and technical units for their support and professionalism.
[Show full text]
Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells In
bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Single-cell transcriptome analysis reveals mesenchymal stem cells 2 in cavernous hemangioma 3 Fulong Ji1$, Yong Liu2$, Jinsong Shi3$, Chunxiang Liu1, Siqi Fu1 4 Heng Wang1, Bingbing Ren1, Dong Mi4, Shan Gao2*, Daqing Sun1* 5 1 Department of Paediatric Surgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China. 6 China. 7 2 College of Life Sciences, Nankai University, Tianjin, Tianjin 300071, P.R. China; 8 3 National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of 9 Medicine, Nanjing, Jiangsu 210016, P.R. China; 10 4 School of Mathematical Sciences, Nankai University, Tianjin, Tianjin 300071, P.R. China; 11 12 13 $ These authors contributed equally to this paper. 14 * Corresponding authors. 15 SG：[email protected] 16 DS：[email protected] 17 bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 18 Abstract 19 A cavernous hemangioma, well-known as vascular malformation, is present at birth, grows 20 proportionately with the child, and does not undergo regression.
[Show full text]
Arxiv:2105.12807V2 [Q-Bio.GN] 4 Jul 2021 CE6T Odn Kand UK ∗ London, 6BT, WC1E 1 Nfr Aiodapoiainadpoeto (UMAP) Projection and Other and 2008] Data
arXiv, 2021, pp. 1–12 Preprint XOmiVAE Problem Solving Protocol PROBLEM SOLVING PROTOCOL XOmiVAE: an interpretable deep learning model for cancer classification using high-dimensional omics data Eloise Withnell,1,2,† Xiaoyu Zhang,1,∗,† Kai Sun1 and Yike Guo1,3 1Data Science Institute, Imperial College London, SW7 2AZ, London, UK, 2Department of Health Informatics, University College London, WC1E 6BT, London, UK and 3Department of Computer Science, Hong Kong Baptist University, Hong Kong, China ∗Corresponding author. [email protected]†The first two authors contributed equally to this paper. Abstract The lack of explainability is one of the most prominent disadvantages of deep learning applications in omics. This “black box” problem can undermine the credibility and limit the practical implementation of biomedical deep learning models. Here we present XOmiVAE, a variational autoencoder (VAE) based interpretable deep learning model for cancer classification using high-dimensional omics data. XOmiVAE is capable of revealing the contribution of each gene and latent dimension for each classification prediction, and the correlation between each gene and each latent dimension. It is also demonstrated that XOmiVAE can explain not only the supervised classification but the unsupervised clustering results from the deep learning network. To the best of our knowledge, XOmiVAE is one of the first activation level-based interpretable deep learning models explaining novel clusters generated by VAE. The explainable results generated by XOmiVAE were validated by both the performance of downstream tasks and the biomedical knowledge. In our experiments, XOmiVAE explanations of deep learning based cancer classification and clustering aligned with current domain knowledge including biological annotation and academic literature, which shows great potential for novel biomedical knowledge discovery from deep learning models.
[Show full text]
Anti-LYVE1 Polyclonal Antibody [Biotin] (DPABY- 520) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
Anti-LYVE1 polyclonal antibody [Biotin] (DPABY- 520) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description View LYVE-1 IHC images. Specificity Detects LYVE-1 in ELISAs and Western blots. In sandwich immunoassays, less than 0.1% cross-reactivity with recombinant mouse LYVE-1 is observed. Immunogen Mouse myeloma cell line NS0-derived recombinant human LYVE-1. Ser24-Thr238 Accession Number Q9Y5Y7 Isotype IgG Source/Host Goat Species Reactivity Human Purification Antigen Affinity-purified Conjugate Biotin Applications Western Blot, Immunohistochemistry, ELISA Detection (Matched Pair) Procedure Matched Antibody Pairs Format Liquid Size 50 μg Buffer Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. Preservative None Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. GENE INFORMATION Gene Name LYVE1 lymphatic vessel endothelial hyaluronan receptor 1 [ Homo sapiens (human) ] 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Official Symbol LYVE1 Synonyms LYVE1; lymphatic vessel endothelial hyaluronan receptor 1; HAR; XLKD1; LYVE-1; CRSBP-1; lymphatic vessel endothelial hyaluronic acid receptor 1; hyaluronic acid receptor;
[Show full text]
Single-Cell Mapping Reveals New Markers and Functions of Lymphatic Endothelial Cells in Lymph Nodes
bioRxiv preprint doi: https://doi.org/10.1101/2020.01.09.900241; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Single-cell mapping reveals new markers and functions of lymphatic endothelial cells in lymph nodes Noriki Fujimoto1,2,$, Yuliang He1,$, Marco D’Addio1, Carlotta Tacconi1, Michael Detmar1,*, Lothar C. Dieterich1,* 1 Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland 2 Department of Dermatology, Shiga University of Medical Sciences, Japan $ These authors have contributed equally to this work * Correspondence: Lothar C. Dieterich, Ph.D. or Michael Detmar, M.D. Institute of Pharmaceutical Sciences, ETH Zurich Vladimir-Prelog-Weg 1-5/10 8093 Zurich, Switzerland E-mail: [email protected] or [email protected] Phone: +41 44 633 7392 Fax: +41 44 633 1364 Running title: Single-cell mapping of lymph node LECs bioRxiv preprint doi: https://doi.org/10.1101/2020.01.09.900241; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Lymph nodes (LNs) are highly organized secondary lymphoid organs that mediate adaptive immune responses to antigens delivered via afferent lymphatic vessels.
[Show full text]
Human LYVE-1 Accusignal ELISA Kit - KOA0597
Human LYVE-1 AccuSignal ELISA Kit - KOA0597 Code: KOA0597 Size: 1 Kit Product Description: Human LYVE-1 AccuSignal ELISA Kit - KOA0597 PhysicalState: Label Unconjugated Gene Name LYVE1 Species Reactivity Human Storage Condition Store vials at 4°C prior to opening. Centrifuge product if not completely clear after standing at room temperature. This product is stable for 6 months at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage freeze at -20°C or below for 12 months. Avoid cycles of freezing and thawing. Synonyms cell surface retention sequence binding protein-1, Cell surface retention sequence-binding protein 1, CRSBP-1, CRSBP1, extracellular link domain containing 1, extracellular link domain-containing 1, Extracellular link domain-containing protein 1, HAR, Hyaluronic acid receptor, lymphatic vessel endothelial hyaluronan receptor 1, Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1, LYVE1, LYVE1_HUMAN, XLKD1 Application Note Useful in Sandwich ELISA for Quantitative Detection of Antigen. Aliquot 0.1ml per well of the 2000pg/ml, 1000pg/ml, 500pg/ml, 250pg/ml, 125pg/ml, 62.5pg/ml, 31.2pg/ml human LYVE-1 standard solutions into the precoated 96-well plate. Add 0.1ml of the sample diluent buffer into the control well (Zero well). Add 0.1ml of each properly diluted sample of human cell culture supernates, cell lysates or tissue homogenates to each empty well. It is recommended that each human LYVE-1 standard solution and each sample be measured in duplicate. Background Extracellular link domain containing 1, also known as LYVE-1 or XLKD1 is a human gene.
[Show full text]
Predictive Modeling of Type 1 Diabetes Stages Using Disparate Data Sources
Page 1 of 66 Diabetes Predictive Modeling of Type 1 Diabetes Stages Using Disparate Data Sources Brigitte I. Frohnert1, Bobbie-Jo Webb-Robertson2, Lisa M. Bramer2, Sara M. Reehl2, Kathy Waugh1 Andrea K. Steck1, Jill M. Norris3, Marian Rewers1 1Barbara Davis Center for Diabetes, School of Medicine, University of Colorado, Aurora, CO. 2Computational and Statistical Analytics Division, Pacific Northwest National Laboratory, Richland, WA 3Department of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, CO * Address correspondence to: Brigitte I. Frohnert, MD, PhD Assistant Professor of Pediatrics University of Colorado School of Medicine 1775 Aurora Court, B-140, Aurora, CO, 80045 Tel. 303-724-2323 Fax 303-724-6889 Email: [email protected] Running title: Integrative modeling of type 1 diabetes risk 3 Tables, 4 Figures Total Word Count: 3999 1 Diabetes Publish Ahead of Print, published online November 18, 2019 Diabetes Page 2 of 66 ABSTRACT This study aims to model genetic, immunologic, metabolomic and proteomic biomarkers for development of islet autoimmunity (IA) and progression to type 1 diabetes in a prospective high- risk cohort. We studied 67 children: 42 who developed IA (20/42 progressed to diabetes) and 25 controls matched for sex and age. Biomarkers were assessed at four time points: earliest available sample, just prior to IA, just after IA, and just prior to diabetes onset. Predictors of IA and progression to diabetes were identified across disparate sources using an integrative machine learning algorithm and optimization-based feature selection. Our integrative approach was predictive of IA (AUC 0.91) and progression to diabetes (AUC 0.92) based on standard cross- validation (CV).
[Show full text]
Single-Cell Mapping Reveals New Markers and Functions of Lymphatic Endothelial Cells in Lymph Nodes
bioRxiv preprint doi: https://doi.org/10.1101/2020.01.09.900241; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Single-cell mapping reveals new markers and functions of lymphatic endothelial cells in lymph nodes Noriki Fujimoto1,2,$, Yuliang He1,$, Marco D’Addio1, Carlotta Tacconi1, Michael Detmar1,*, Lothar C. Dieterich1,* 1 Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland 2 Department of Dermatology, Shiga University of Medical Sciences, Japan $ These authors have contributed equally to this work * Correspondence: Lothar C. Dieterich, Ph.D. or Michael Detmar, M.D. Institute of Pharmaceutical Sciences, ETH Zurich Vladimir-Prelog-Weg 1-5/10 8093 Zurich, Switzerland E-mail: [email protected] or [email protected] Phone: +41 44 633 7392 Fax: +41 44 633 1364 Running title: Single-cell mapping of lymph node LECs bioRxiv preprint doi: https://doi.org/10.1101/2020.01.09.900241; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Lymph nodes (LNs) are highly organized secondary lymphoid organs that mediate adaptive immune responses to antigens delivered via afferent lymphatic vessels.
[Show full text]